Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 8Terminated 2Withdrawn 1Unknown 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Myelodysplastic Syndromes 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Leukemia, Myeloid, Acute 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Lymphoma, Non-Hodgkin 4Leukemia, Myelomonocytic, Juvenile 3Multiple Myeloma 2Lymphoma 2Leukemia, Biphenotypic, Acute 2Hodgkin Disease 2Hematologic Neoplasms 2Breast Neoplasms 2Shwachman-Diamond Syndrome 1Sarcoma, Myeloid 1Retinoblastoma 1Primary Immunodeficiency Diseases 1Neutropenia, Severe Congenital, Autosomal Recessive 3 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Medulloblastoma 1Macrophage Activation Syndrome 1Lymphoproliferative Disorders 1Lymphoma, Large B-Cell, Diffuse 1Lymphohistiocytosis, Hemophagocytic 1Leukemia, Large Granular Lymphocytic 1Leukemia 1Histiocytosis, Langerhans-Cell 1Histiocytosis 1Hemoglobinopathies 1Bone Marrow Failure Disorders 1

Interventions

Magnetic Resonance Spectroscopy 9Cyclophosphamide 8Specimen Handling 7X-Rays 6Phantoms, Imaging 6Vincristine 5Nuclear Medicine Department, Hospital 5Cisplatin 5Temozolomide 4Radiotherapy 4Biopsy 4Lomustine 3Etoposide 3Carboplatin 3ulixertinib 2tipifarnib 2selpercatinib 2pembrolizumab 2palbociclib 2larotrectinib 2ivosidenib 2erdafitinib 2ensartinib 2Radiation 2Platinum 2Irinotecan 21,2-diaminocyclohexaneplatinum II citrate 2tazemetostat 1omburtamab I-131 1olaparib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Medulloblastoma × Thiotepa × Clear all
NCT02875314 2026-06-03

HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors

Nationwide Children's Hospital

Phase 4 Active not recruiting
250 enrolled
CNS

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡